Cargando…
Network Pharmacology and Molecular Docking Elucidate the Pharmacological Mechanism of the OSTEOWONDER Capsule for Treating Osteoporosis
Background: Osteoporosis (OP) is a serious and common bone metabolic disease with bone mass loss and bone microarchitectural deterioration. The OSTEOWONDER capsule is clinically used to treat OP. However, the potential regulatory mechanism of the OSTEOWONDER capsule in treatment of OP remains largel...
Autores principales: | Fan, Jiashuang, Zhou, Jianli, Qu, Zhuan, Peng, Hangya, Meng, Shuhui, Peng, Yaping, Liu, Tengyan, Luo, Qiu, Dai, Lifen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918533/ https://www.ncbi.nlm.nih.gov/pubmed/35295951 http://dx.doi.org/10.3389/fgene.2022.833027 |
Ejemplares similares
-
Comprehensive analysis of the m6A-related molecular patterns and diagnostic biomarkers in osteoporosis
por: Bai, Qiong, et al.
Publicado: (2022) -
Study on complications of osteoporosis based on network pharmacology
por: Song, Zhijing, et al.
Publicado: (2022) -
Network pharmacology and molecular docking approach to elucidate the mechanisms of Liuwei Dihuang pill in diabetic osteoporosis
por: Lu, Zhaoqi, et al.
Publicado: (2022) -
Network pharmacology- and molecular docking-based approaches to unveil the pharmacological mechanisms of dihydroartemisinin against esophageal carcinoma
por: Wang, Haixia
Publicado: (2022) -
Network Pharmacology-Based Strategy and Molecular Docking to Explore the Potential Mechanism of Jintiange Capsule for Treating Osteoporosis
por: Yang, Zhao, et al.
Publicado: (2021)